Evidence map›Paper›PMID 26034283›Full record

Trial reportProceedings of the National Academy of Sciences of the United States of America2015

Amphetamine modulates brain signal variability and working memory in younger and older adults.

Douglas D Garrett, Irene E Nagel, Claudia Preuschhof, Agnieszka Z Burzynska, Janina Marchner, Steffen Wiegert, Gerhard J Jungehülsing, Lars Nyberg, Arno Villringer, Shu-Chen Li and 3 more

Registry-linked trialOpen access · bronzeAbstract readClinical Trial
In one paragraph

Trial report in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04191811 (Moment-to-moment Neural Variability as a Predictor of Treatment Outcome in Patients With Common Psychiatric Disorders), which is not on this map. Cited by 57 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 2 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04191811 recruitingnot on this mapstarted 2022, after this paper: background citation

Moment-to-moment Neural Variability as a Predictor of Treatment Outcome in Patients With Common Psychiatric Disorders: Major Depressive Disorder, Insomnia and Social Anxiety Disorder

TypeobservationalSponsorKarolinska InstitutetRan2022 to 2026Enrolled150ConditionsPsychiatric Disorder, Depression, Anxiety Disorders, InsomniaArmsInternet-delivered cognitive behavioral therapy for major depressive disorder, Internet-delivered cognitive behavioral therapy for insomnia, Internet-delivered cognitive behavioral therapy for social anxiety disorder
3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 2 syntheses or guidelines pooled it, 117 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Dynamic Recovery: GABA Agonism Restores Neural Variability in Older, Poorer Performing Adults.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2021
    Trial
  6. Trial
  7. Trial
  8. Dopaminergic mechanisms supporting hippocampal postencoding dynamics in humans.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 4 countries.

Douglas D GarrettCenter for Lifespan Psychology, Max Planck Institute for Human Development, 14195 Berlin, Germany; Max Planck UCL Centre for Computational Psychiatry and Ageing Research, 14195 Berlin, Germany; garrett@mpib-berlin.mpg.de.
Irene E NagelCenter for Lifespan Psychology, Max Planck Institute for Human Development, 14195 Berlin, Germany; Department of Education and Psychology, Freie Universität Berlin, 14195 Berlin, Germany;
Claudia PreuschhofCenter for Lifespan Psychology, Max Planck Institute for Human Development, 14195 Berlin, Germany; Department of Education and Psychology, Freie Universität Berlin, 14195 Berlin, Germany; Department of Clinical Developmental Psychology, Center for Behavioral and Brain Sciences, Otto von Guericke University Magdeburg, 39106 Magdeburg, Germany;
Agnieszka Z BurzynskaCenter for Lifespan Psychology, Max Planck Institute for Human Development, 14195 Berlin, Germany; Beckman Institute for Advanced Science and Technology, University of Illinois, Urbana, IL 61820;
Janina MarchnerCenter for Lifespan Psychology, Max Planck Institute for Human Development, 14195 Berlin, Germany;
Steffen WiegertCenter for Lifespan Psychology, Max Planck Institute for Human Development, 14195 Berlin, Germany;
Gerhard J JungehülsingKlinik für Neurologie, Jüdisches Krankenhaus, 13347 Berlin, Germany;
Lars NybergDepartments of Radiation Sciences and Integrative Medical Biology, and Umeå Center for Functional Brain Imaging, Umeå University, SE-901 87 Umeå, Sweden;
Arno VillringerMax Planck Institute for Human Cognitive and Brain Sciences, 04103 Leipzig, Germany;
Shu-Chen LiCenter for Lifespan Psychology, Max Planck Institute for Human Development, 14195 Berlin, Germany; Department of Psychology, TU Dresden, 01062 Dresden, Germany;
Hauke R HeekerenCenter for Lifespan Psychology, Max Planck Institute for Human Development, 14195 Berlin, Germany; Department of Education and Psychology, Freie Universität Berlin, 14195 Berlin, Germany; Max Planck Institute for Human Cognitive and Brain Sciences, 04103 Leipzig, Germany;
Lars BäckmanAging Research Center, Karolinska Institute, SE-113 30 Stockholm, Sweden.
Ulman LindenbergerCenter for Lifespan Psychology, Max Planck Institute for Human Development, 14195 Berlin, Germany; Max Planck UCL Centre for Computational Psychiatry and Ageing Research, 14195 Berlin, Germany;
Max Planck Institute for Human Development · DEInstitute of Developmental Physiology · RUJüdisches Krankenhaus Berlin · DEKarolinska Institutet · SEMax Planck Institute for Human Cognitive and Brain Sciences · DEMax Planck Society · DEUmeå University · SEUniversity of Illinois Urbana-Champaign · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Better-performing younger adults typically express greater brain signal variability relative to older, poorer performers. Mechanisms for age and performance-graded differences in brain dynamics have, however, not yet been uncovered. Given the age-related decline of the dopamine (DA) system in normal cognitive aging, DA neuromodulation is one plausible mechanism. Hence, agents that boost systemic DA [such as d-amphetamine (AMPH)] may help to restore deficient signal variability levels. Furthermore, despite the standard practice of counterbalancing drug session order (AMPH first vs. placebo first), it remains understudied how AMPH may interact with practice effects, possibly influencing whether DA up-regulation is functional. We examined the effects of AMPH on functional-MRI-based blood oxygen level-dependent (BOLD) signal variability (SD(BOLD)) in younger and older adults during a working memory task (letter n-back). Older adults expressed lower brain signal variability at placebo, but met or exceeded young adult SD(BOLD) levels in the presence of AMPH. Drug session order greatly moderated change-change relations between AMPH-driven SD(BOLD) and reaction time means (RT(mean)) and SDs (RT(SD)). Older adults who received AMPH in the first session tended to improve in RT(mean) and RT(SD) when SD(BOLD) was boosted on AMPH, whereas younger and older adults who received AMPH in the second session showed either a performance improvement when SD(BOLD) decreased (for RT(mean)) or no effect at all (for RT(SD)). The present findings support the hypothesis that age differences in brain signal variability reflect aging-induced changes in dopaminergic neuromodulation. The observed interactions among AMPH, age, and session order highlight the state- and practice-dependent neurochemical basis of human brain dynamics.

Indexed as

AdultAgedAgingBrainDextroamphetamineDopamineDouble-Blind MethodFemaleFunctional NeuroimagingHumansLeast-Squares AnalysisMagnetic Resonance ImagingMaleMemory, Short-TermMiddle AgedModels, NeurologicalDextroamphetamineDopamineagingbrain signal variabilitydopaminefMRIworking memory

Identifiers

PMID26034283
PMCPMC4475975
OpenAlexW2134174619

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.